[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1468692T3 - Anvendelse af 2,6-di-alkyl-4-silyl-phenoler til behandling af xantom - Google Patents

Anvendelse af 2,6-di-alkyl-4-silyl-phenoler til behandling af xantom

Info

Publication number
DK1468692T3
DK1468692T3 DK04016883T DK04016883T DK1468692T3 DK 1468692 T3 DK1468692 T3 DK 1468692T3 DK 04016883 T DK04016883 T DK 04016883T DK 04016883 T DK04016883 T DK 04016883T DK 1468692 T3 DK1468692 T3 DK 1468692T3
Authority
DK
Denmark
Prior art keywords
alkyl
xanthoma
silyl
phenols
treatment
Prior art date
Application number
DK04016883T
Other languages
Danish (da)
English (en)
Inventor
Simon Jen Tan Mao
Mark Thirston Yates
Roger Alan Parker
Original Assignee
Aventis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Inc filed Critical Aventis Inc
Application granted granted Critical
Publication of DK1468692T3 publication Critical patent/DK1468692T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
DK04016883T 1993-12-10 1994-11-03 Anvendelse af 2,6-di-alkyl-4-silyl-phenoler til behandling af xantom DK1468692T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16528193A 1993-12-10 1993-12-10
EP95901141A EP0732928B1 (de) 1993-12-10 1994-11-03 Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten

Publications (1)

Publication Number Publication Date
DK1468692T3 true DK1468692T3 (da) 2006-08-28

Family

ID=22598245

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04016883T DK1468692T3 (da) 1993-12-10 1994-11-03 Anvendelse af 2,6-di-alkyl-4-silyl-phenoler til behandling af xantom
DK95901141T DK0732928T3 (da) 1993-12-10 1994-11-03 Fremgangsmåde til sænkning af serumcholesterolnuiveauer med 2,6-di-alkyl-4-silyl-phenoler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK95901141T DK0732928T3 (da) 1993-12-10 1994-11-03 Fremgangsmåde til sænkning af serumcholesterolnuiveauer med 2,6-di-alkyl-4-silyl-phenoler

Country Status (16)

Country Link
EP (3) EP1468693A3 (de)
JP (1) JPH09511222A (de)
CN (1) CN1092517C (de)
AT (2) ATE324113T1 (de)
AU (1) AU681731B2 (de)
CA (1) CA2177968C (de)
DE (2) DE69434720T2 (de)
DK (2) DK1468692T3 (de)
ES (2) ES2233937T3 (de)
HU (1) HU220761B1 (de)
IL (1) IL111905A (de)
NO (1) NO311868B1 (de)
NZ (1) NZ276285A (de)
PT (2) PT1468692E (de)
WO (1) WO1995015760A1 (de)
ZA (1) ZA949663B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100453530C (zh) * 1997-05-14 2009-01-21 阿特罗吉尼克斯公司 抑制vcam-1表达的化合物及其药物组合物
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
PT998477E (pt) * 1997-06-24 2003-07-31 Aventis Pharma Inc Fenois e tiofenois alquil-4-silil-heterociclicos como agentes antioxidantes
AU7588498A (en) * 1997-06-25 1999-01-04 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-{ (dimethyl-4-methoxyphenylsilyl) -methyloxy}phenol and 2,6-di-t-butyl-4-{ (dimethyl-2-methoxy-phenylsilyl) -methyloxy}phenol
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
CA2294247C (en) 1997-07-01 2004-10-26 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
ATE326014T1 (de) * 1998-11-09 2006-06-15 Atherogenics Inc Methode und zusammensetzungen zum vermindern des cholesterolspiegels im plasma
US6887712B1 (en) 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
US6821738B2 (en) 1999-01-20 2004-11-23 The Board Of Regents For Oklahoma State University Broad spectrum bio-detection of nerve agents, organophosphates, and other chemical warfare agents
CA2428753C (en) 2000-11-17 2013-05-21 Idenix (Cayman) Limited Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
US7094801B2 (en) 2001-12-19 2006-08-22 Atherogenics, Inc. Chalcone derivatives and their use to treat diseases
CA2492433A1 (en) 2002-07-12 2004-01-22 Artherogenics, Inc. Organic amine salts of poorly soluble probucol esters and ethers
US7173129B2 (en) 2003-06-06 2007-02-06 Athero Genics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
JP2007509054A (ja) * 2003-10-17 2007-04-12 アミリン・ファーマシューティカルズ，インコーポレイテッド 血管健康を促進するシリルフェノール
WO2005112914A2 (en) 2004-04-20 2005-12-01 Atherogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
BRPI0809423A2 (pt) 2007-03-26 2014-09-09 Salutria Pharmaceuticals Llc Usos e composições de derivados de probucol para o tratamento de diabetes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE349046B (de) * 1966-12-23 1972-09-18 C Guevne
FR2230376A1 (en) * 1973-05-24 1974-12-20 Gueyne Jean Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity
FR2308372A2 (fr) * 1975-04-21 1976-11-19 Cortial Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif
US4670421A (en) * 1982-07-12 1987-06-02 American Cyanamid Company Antiatherosclerotic silanes
US4900757A (en) * 1988-12-08 1990-02-13 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
NZ238807A (en) * 1990-07-05 1994-03-25 Merrell Dow Pharma Bis[4-(2,6-dialkyl)phenol]silane derivatives and antiatherosclerotic compositions
US5155250A (en) * 1990-07-05 1992-10-13 Merrell Dow Pharmaceuticals Inc. 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents

Also Published As

Publication number Publication date
HU220761B1 (hu) 2002-05-28
EP0732928A1 (de) 1996-09-25
ES2233937T3 (es) 2005-06-16
NO962415L (no) 1996-06-07
AU1049995A (en) 1995-06-27
PT1468692E (pt) 2006-09-29
ATE324113T1 (de) 2006-05-15
DE69434720D1 (de) 2006-06-01
ES2263094T3 (es) 2006-12-01
DE69434720T2 (de) 2007-05-16
ATE285238T1 (de) 2005-01-15
EP1468693A2 (de) 2004-10-20
EP1468692A3 (de) 2004-11-03
EP1468693A3 (de) 2004-11-03
EP1468692B1 (de) 2006-04-26
NO311868B1 (no) 2002-02-11
CA2177968A1 (en) 1995-06-15
WO1995015760A1 (en) 1995-06-15
NO962415D0 (no) 1996-06-07
DE69434198T2 (de) 2005-12-29
CA2177968C (en) 2000-03-28
DE69434198D1 (de) 2005-01-27
AU681731B2 (en) 1997-09-04
HU9601590D0 (en) 1996-08-28
IL111905A (en) 2001-04-30
CN1140995A (zh) 1997-01-22
IL111905A0 (en) 1995-03-15
CN1092517C (zh) 2002-10-16
JPH09511222A (ja) 1997-11-11
DK0732928T3 (da) 2005-04-18
NZ276285A (en) 2004-11-26
ZA949663B (en) 1995-08-15
EP0732928B1 (de) 2004-12-22
EP1468692A2 (de) 2004-10-20
HUT74015A (en) 1996-10-28
PT732928E (pt) 2005-03-31

Similar Documents

Publication Publication Date Title
DK1468692T3 (da) Anvendelse af 2,6-di-alkyl-4-silyl-phenoler til behandling af xantom
MX9203122A (es) Compuestos analogos de distamicina a y composiciones farmaceuticas que los contienen.
ID29452A (id) 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus
DE69736642D1 (de) Heterocyclische Verbindungen, ihre Herstellung und Verwendung
NO179142C (no) 3-benzyliden-1-karbamoyl-2-pyrrolidon-analoger
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
EP0632031A4 (de)
FI864618A (fi) Nya 3-oxadiazol- och 3-karboksylsyra- -karbolinderivat, deras framstaellning och deras anvaendning som laekemedel.
DK0410305T3 (da) Anvendelse af bis(4-hydroxyphenylthio)methanderivater til behandling af diabetes mellitus
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater
NO960308L (no) Terapeutisk aktive benzoksaziner og benzotioanoner
ATE156487T1 (de) Mercapto-acetamid-derivate
ES8800663A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
ATE143591T1 (de) Verwendung von bis-(p- hydroxyphenylthio)methanderivaten zur hemmung der fortschreitenden entwicklung von insulinabhängingem diabetes mellitus
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.